Filipski, K
59  Ergebnisse:
Personensuche X
?
1

P01.16.B Neurocognitive outcome and seizure freedom after a..:

Reitz, S ; Behrens, M ; Lortz, I...
Neuro-Oncology.  24 (2022)  Supplement_2 - p. ii27-ii27 , 2022
 
?
2

P14.11 Severe treatment-induced myelosuppression is more fr..:

Zeiner, P S ; Filipski, K ; Forster, M...
Neuro-Oncology.  23 (2021)  Supplement_2 - p. ii39-ii40 , 2021
 
?
 
?
7

Contribution of Organic Cation Transporter 2 (OCT2) to Cisp..:

Filipski, K K ; Mathijssen, R H ; Mikkelsen, T S..
Clinical Pharmacology & Therapeutics.  86 (2009)  4 - p. 396-402 , 2009
 
?
8

Pharmacoepidemiology: A time for a new multidisciplinary ap..:

Issa, Amalia M. ; Carleton, Bruce ; Gerhard, Tobias...
Pharmacoepidemiology and Drug Safety.  30 (2021)  8 - p. 985-992 , 2021
 
?
9

Survivorship for Individuals Living With Advanced and Metas..:

Mollica, Michelle A ; Smith, Ashley Wilder ; Tonorezos, Emily...
JNCI: Journal of the National Cancer Institute.  114 (2021)  4 - p. 489-495 , 2021
 
?
11

Clinical decisions surrounding genomic and proteomic testin..:

Efimova, Olga ; Berse, Brygida ; Denhalter, Daniel W....
BMC Medical Informatics and Decision Making.  17 (2017)  1 - p. , 2017
 
1-15